| Similar Articles |
|---|
 |
BusinessWeek
July 5, 2004 |
The Heart Is Just the Start CEO Art Collins explains how Medtronics is moving into treating spinal injuries, neurological disorders, diabetes, and more.   |
BusinessWeek
March 7, 2005
Michael Arndt |
"Pacemakers" for the Rest of You Slews of tiny devices that deliver electrical stimulation to a wide variety of organs should soon become available. |
The Motley Fool
February 17, 2009
Brian Orelli |
Investors Heart Medtronic The leaner company is more lovable. |
BusinessWeek
March 7, 2005
Michael Arndt |
Rewiring The Body First came pacemakers. Now exotic implants are bringing new hope to victims of epilepsy, paralysis, depression, and other diseases. And some of the biggest names in health care are in a scramble to get into the market. |
BusinessWeek
March 7, 2005 |
Dr. Oesterle's Stimulating Work Medtronic's chief medical officer, Dr. Stephen N. Oesterle, discusses the progress and potential of using "implanted pulse generators" to treat chronic ailments. |
The Motley Fool
November 9, 2005
Stephen D. Simpson |
Greatbatch Keeps Growth Pumping Demand for implantable medical electronics keeps this battery and component maker humming. Investors new to this stock and/or medical technology in general will need to exercise some patience. |
The Motley Fool
February 17, 2005
Stephen D. Simpson |
Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock? |
The Motley Fool
May 26, 2005
Stephen D. Simpson |
A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges? |
The Motley Fool
January 6, 2005
Stephen D. Simpson |
Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past. |
Knowledge@Wharton
March 26, 2003 |
An Aging, Fatter Population Drives Demand for New Medical Devices The use of implantable devices to treat heart disease, orthopedic complaints and other conditions is growing strongly because of advancing technology, increasing demand from an ageing and overweight population, and greater acceptance by physicians and patients of implantation. |
The Motley Fool
May 26, 2004
Alyce Lomax |
Medtronic Takes Heart After the stock drops on data, what does the company have to say? |
The Motley Fool
August 25, 2009
Brian Orelli |
Medtronic Takes the Road Less Traveled It looks like this medical devices company is healthy again. |
The Motley Fool
May 24, 2007
Ryan Fuhrmann |
Chronic Healthiness at Medtronic The med-tech firm isn't growing as fast as it once was, but its fourth-quarter earnings report still managed to beat Wall Street's expectations. |
The Motley Fool
November 18, 2004
W.D. Crotty |
Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy. |
The Motley Fool
October 17, 2005
Stephen D. Simpson |
A Busy Day for St. Jude In addition to announcing a major acquisition, St. Jude also reported very solid financial results for the third quarter. Analysts keep raising the bar, and the medical equipment company continues to surpass it. |
The Motley Fool
March 29, 2011
Brian Orelli |
Medtronic's Exciting New Toys The device maker received multiple approvals in less than a week. |
The Motley Fool
May 10, 2011
Arundhati Parmar |
Medtronic's MR-Conditional Pacemaker Likely Too Expensive Is Medtronic's pricing choice dragging on this breakthrough product? |
The Motley Fool
August 20, 2008
Brian Orelli |
Medtronic Muddles Through The medical device maker manages double-digit growth in a tough market. |
The Motley Fool
May 21, 2008
Brian Orelli |
Medtronic's Endeavors Look Good The medical device maker's new drug-eluting stent helps push up revenue. |
The Motley Fool
April 20, 2005
Stephen D. Simpson |
St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well. |
The Motley Fool
October 16, 2007
Billy Fisher |
A Heartbreaker at Medtronic The medical device maker halts distribution of certain defibrillator wires. Shares of Medtronic are now very close to the stock's 52-week low. |
The Motley Fool
February 24, 2010
Brian Orelli |
Medtronic Needs to Regrow a Spine Everything else looks fairly good, but the problem I see involves the slight decline in Medtronic's second-largest segment, spinal products. |
The Motley Fool
May 24, 2006
S.J. Caplan |
Goodbye, Guidant Publicity woes drive Boston Scientific to ditch the Guidant name. In the meantime, Boston Scientific wants to capitalize on its entry into the ICD market, an area experiencing double-digit sales growth. Investors, take note. |
The Motley Fool
June 29, 2005
Stephen D. Simpson |
Medtronic Makes a Fat Deal Medtronic's purchase of the developer of an "obesity pacemaker" could reap rewards in a few years. Investors, take note. |
BusinessWeek
October 29, 2007
Arlene Weintraub |
Medtronic's Uncertain Endeavor The drug-coated stent might have made up for Medtronic's recent product recall, but renewed scrutiny of the device has executives scaling back expectations |
The Motley Fool
October 23, 2006
Michael P. Cecil |
Are Pacemaker Prices Heading for a Fall? Medicare law changes may drive the amount that hospitals can pay for pacemakers. Will device makers be forced to lower prices? Investors, take note. |
The Motley Fool
February 12, 2004
Jeff Hwang |
Rockin' Medtronic The world's premier medical device maker keeps on growing. |
The Motley Fool
August 18, 2005
Stephen D. Simpson |
Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay. |
The Motley Fool
February 20, 2008
Brian Orelli |
Medtronic Looks Ahead After a rough second half of last year, Medtronic is leaving its problems behind, and optimistically focusing on the future. |
The Motley Fool
November 21, 2006
Ryan Fuhrmann |
Shocking Results at Medtronic Favorable earnings boost shares of this medical equipment maker -- but are they too high already? |
The Motley Fool
November 17, 2010
Bryan Hinmon |
Rising Star Buy: Medtronic Find out why this medical technology giant takes a place in our Un Portfolio. |
The Motley Fool
October 4, 2004
Selena Maranjian |
When Medicare Boosts Stocks More defibrillators in use means higher earnings for some investors. |
The Motley Fool
April 19, 2007
Billy Fisher |
A Saintly Quarter Shares of St. Jude Medical rise after the company announces a big quarter. |
The Motley Fool
May 25, 2010
Brian Orelli |
Medtronic Gets Tossed Out With the Bathwater A bad day to report good news. |
BusinessWeek
May 29, 2006
Gene G. Marcial |
Will Medtronic's Pulse Quicken? Some investors say Medtronic may beat analysts' consensus forecast. |
The Motley Fool
April 27, 2011
Arundhati Parmar |
Medtronic and Eli Lilly Join Hands to Combat Parkinson's Disease The partnership aims to research and develop a new approach to treating the debilitating disease. |
The Motley Fool
August 24, 2011
Arundhati Parmar |
Growth Is the Deity Medtronic CEO Omar Ishrak Will Worship CEO Omar Ishrak repeatedly said that a singular focus on growth would be his top priority to transform the company. |
The Motley Fool
December 29, 2011
Harsh Chauhan |
Why Medtronic Is On Course for a Happy New Year Right moves make Medtronic a good investment now. |
The Motley Fool
January 26, 2005
Stephen D. Simpson |
St. Jude Is No Lost Cause The No. 3 cardiology company posts solid growth because of continuing implantable cardioverter defibrillator (ICD) market share gains. |
The Motley Fool
December 31, 2007
Brian Orelli |
Boston Scientific Restarts Its Heart Boston Scientific receives European approval for its defibrillator, giving the company a revenue boost even if the U.S. approval is delayed. |
IEEE Spectrum
September 2006
Kieron Murphy |
Q&A With: Michael Weiner We talk with the CEO of Biophan Technologies, a cutting-edge developer of biomedical device components about the industry, how his company fits into the med-tech market and how engineering contributes to improving quality of life. |
The Motley Fool
November 24, 2009
Brian Orelli |
52-Week Highs! What's Going On? Even with its recent leap, this stock may belong in your portfolio. Medtronic raised earnings guidance today after a fairly strong quarter, and the stock is hitting new 52-week highs. |
The Motley Fool
December 9, 2011
Harsh Chauhan |
Medtronic Regains Its Footing Medtronic comes up with a strong quarter. |
The Motley Fool
June 1, 2005
T.G. Wolf |
A Shocking Opportunity? Advanced Neuromodulation Systems has been competing quite nicely with the big boys in the emerging neurodevice segment of the neurotech industry. Investors, take note. |
The Motley Fool
July 25, 2011
Jason Moser |
Rising Star Buy: St. Jude Medical It's a good time to jump in on this medical-device maker. |
The Motley Fool
March 2, 2011 |
Fool Q&A: Medtronic CFO Gary Ellis The medical-device maker's chief financial officer talks R&D, "One Medtronic," and growth in emerging markets. |
The Motley Fool
April 27, 2011
Brian Orelli |
Don't Get Pumped Up About Pumping It In Medtronic and Eli Lilly team up against Parkinson's. |
The Motley Fool
August 18, 2008
Brian Orelli |
Foolish Forecast: Taking Medtronic to Heart In advance of earnings analysts expect Medtronic, with another medical device approval, to boost revenues 17%. |
The Motley Fool
October 19, 2007
Billy Fisher |
Keeping Pace at St. Jude Medical device maker St. Jude Medical has a strong quarter, but investors weren't impressed. |
The Motley Fool
August 24, 2010
Brian Orelli |
Disaster in Medical-Device Land Industry bellwether Medtronic is forecasting a nasty storm. |
